As ALS Awareness Month 2012 comes to a close, Bob would like to ask one thing of everyone reading this: Make every day an ALS Awareness Day.
Articles from May 2012
Not only was Mr. Gehrig a study in baseball perfection, but also a model of courage and dignity.
Stevens thinks that their findings might shed light on diseases that involve synapse loss or dysfunction. In neurodegenerative diseases such as glaucoma, Alzheimer’s disease, Lou Gehrig’s disease (ALS), Huntington’s disease and Parkinson’s disease, scientists have noted subtle changes in synapses that might cause them to be targeted for elimination.
The easiest way to help is simply open your heart and open your wallet. We won’t kid you: the ALS community desperately needs funding.
9 out of 10 people today still don’t know what ALS is about. Approximately 3 out of 10 (at best) have ever even heard of “ALS” or “Lou Gehrig’s disease.”
Company requesting permission to evaluate efficacy in its phase 1 safety trial, as well as to increase the dosage and number of trial participants.
Clearly the ALS community still has a long way to go to finding a cure, or even effective treatment options. And that’s also why fundraising is such an important part of what we do here at the RASCALS Foundation.
There are people in whom ALS has stopped progressing and a small number of people in whom the symptoms of ALS reversed.
ALS ultimately results in a total body paralysis, inability to speak, inability to eat or drink by mouth, and inability to breathe unassisted.
Current treatment of ALS is aimed at symptomatic relief, prevention of complications and maintenance of maximum optimal function and optimal quality of life.